Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: V00Y10W60W

Pharmacology

Action Mechanism of Action Reference
OTHER Myeloid cell surface antigen CD33 other PubMed
Primary Target
CD33

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia 3 D007938 ClinicalTrials
Myelodysplastic Syndromes 2 D009190 ClinicalTrials
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Neutropenia 2 D009503 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Leukemia, Myelomonocytic, Chronic 1 D015477 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 166089-32-3
ChEMBL CHEMBL2109150
FDA SRS V00Y10W60W
Guide to Pharmacology 7983